CooperGenomics

CooperGenomics is a company based in Livingston, New Jersey, specializing in reproductive genetic testing. As part of the CooperSurgical family, CooperGenomics employs 85 individuals and generates an annual revenue of $100 million. CooperGenomics offers a range of genetic testing services, including expanded preimplantation genetic testing for aneuploidy (PGT-A) through their PGTai℠ platform, preimplantation genetic testing for monogenic disorders (PGT-M), preimplantation genetic testing for structural rearrangements (PGT-SR), and ERPeak℠ endometrial receptivity testing. These services cater to individuals and families seeking to understand and optimize their reproductive journey. The company distinguishes itself through its commitment to advancing the field of reproductive genetics. CooperGenomics actively invests in research and development to improve testing accuracy and expand the scope of genetic information available to patients and clinicians. Their dedication to innovation and patient empowerment sets them apart in the industry. For more information about CooperGenomics and their services, visit their website at coopergenomics.com.